Neurocrine Biosciences (NBIX) Invested Capital (2017 - 2024)
Neurocrine Biosciences (NBIX) recorded Invested Capital of $2.59 billion in Q4 2024, up 7.8% from $2.4 billion a year earlier but down 4.8% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Invested Capital (2017 - 2024) Analysis & Trends
Starting with Q4 2017, Neurocrine Biosciences' Invested Capital history includes 17 quarters.
- Annual Invested Capital has increased for five straight years, with a five-year compound annual growth rate of 19.9% (FY2019 to FY2024).
- Across earlier years, Invested Capital came in at $2.4 billion in FY2023 (+28.0%), $1.88 billion in FY2022 (+36.6%), $1.37 billion in FY2021 (+22.0%) and $1.13 billion in FY2020 (+7.7%).
- Quarterly Invested Capital has ranged from $1.13 billion in Q4 2020 to $2.72 billion in Q3 2024 over the past five years.
- On a year-over-year basis, Invested Capital has increased for six consecutive quarters, with growth averaging 26.8% over the last six quarters.
- Over the past five years, the year-over-year growth in Invested Capital ranged from 7.7% (Q4 2020) to 48.9% (Q1 2024).
- Per Business Quant, the preceding three quarters came in at $2.72 billion (Q3 2024), $2.51 billion (Q2 2024) and $2.51 billion (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 134.01 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 64.89 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 95.89 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 79.44 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 50.26 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 68.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 38.08 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 148.69 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Neurocrine Biosciences | 14.41 Bn | 10.11 Bn | 935.80 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 2.59 Bn |
| Sep 30, 2024 | 2.72 Bn |
| Jun 30, 2024 | 2.51 Bn |
| Mar 31, 2024 | 2.51 Bn |
| Dec 31, 2023 | 2.40 Bn |
| Sep 30, 2023 | 2.17 Bn |
| Jun 30, 2023 | 2.02 Bn |
| Mar 31, 2023 | 1.68 Bn |
| Dec 31, 2022 | 1.88 Bn |
| Sep 30, 2022 | 1.71 Bn |
| Dec 31, 2021 | 1.37 Bn |
| Dec 31, 2020 | 1.13 Bn |
| Sep 30, 2020 | 1.23 Bn |
| Jun 30, 2020 | 1.25 Bn |
| Dec 31, 2019 | 1.05 Bn |
| Sep 30, 2018 | 831.16 Mn |
| Dec 31, 2017 | 372.20 Mn |
API Access
Neurocrine Biosciences Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();